CUTANEOUS LUPUS

Clinical trials for CUTANEOUS LUPUS explained in plain language.

Never miss a new study

Get alerted when new CUTANEOUS LUPUS trials appear

Sign up with your email to follow new studies for CUTANEOUS LUPUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1

Lupus skin drug shows promise in small trial

Disease control Completed

This study looked at whether tofacitinib, a drug that calms the immune system, is safe and helpful for young adults (ages 18-45) with moderate to severe lupus skin disease. Thirteen people took part over 76 weeks. The goal was to see if the drug reduces skin symptoms and how the …

Matched conditions: CUTANEOUS LUPUS

Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control

Last updated May 05, 2026 11:55 UTC

CUTANEOUS LUPUS

Get alerted when new CUTANEOUS LUPUS trials appear

Lupus skin drug shows promise in small trial